Ionis Pharmaceuticals Financial Statements (IONS)

Ionis Pharmaceuticalssmart-lab.ru %   2019 2020 2021 2022 2023   LTM ?
Report date 02.03.2020 24.02.2021 25.02.2022 22.02.2023 21.02.2024   06.11.2024
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 1 123 729.0 810.0 587.0 787.6   803.1
Operating Income, bln rub 366.0 -172.0 -30.0 -411.0 -353.7   -370.4
EBITDA, bln rub ? 411.5 -107.9 -0.239 -227.8 -230.0   -252.6
Net profit, bln rub ? 294.0 -487.0 -29.0 -270.0 -366.3   -358.8
OCF, bln rub ? 345.7 35.9 30.8 -274.4 -307.5   -351.9
CAPEX, bln rub ? 36.3 41.0 17.9 20.1 28.0   33.0
FCF, bln rub ? 309.4 -5.16 12.9 -294.5 -335.5   -373.4
Dividend payout, bln rub 0.000 0.000 0.000 0.000 0.000   0.000
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 0.00% 0.00% 0.00% 0.00% 0.00%   0
OPEX, bln rub 753.0 889.0 829.0 984.0 779.6   1 152
Cost of production, bln rub 4.00 12.0 11.0 14.0 9.13   21.7
R&D, bln rub 466.0 535.0 643.0 833.0 899.6   912.6
Interest expenses, bln rub 49.0 45.0 4.30 8.12 0.000   85.4
Assets, bln rub 3 233 2 390 2 612 2 534 2 990   3 081
Net Assets, bln rub ? 1 471 843.0 772.0 573.0 386.7   662.5
Debt, bln rub 710.0 749.0 1 161 1 345 1 454   1 447
Cash, bln rub 2 500 1 892 2 115 1 987 2 331   2 483
Net debt, bln rub -1 790 -1 143 -954.0 -642.0 -877.7   -1 037
Ordinary share price, rub 60.4 56.5 30.4 37.8 50.6   43.7
Number of ordinary shares, mln 140.0 139.6 141.0 141.8 143.2   148.6
Market cap, bln rub 8 457 7 894 4 291 5 358 7 244   6 498
EV, bln rub ? 6 667 6 751 3 337 4 716 6 366   5 461
Book value, bln rub 1 445 815 743 573 387   662
EPS, rub ? 2.10 -3.49 -0.21 -1.90 -2.56   -2.41
FCF/share, rub 2.21 -0.04 0.09 -2.08 -2.34   -2.51
BV/share, rub 10.3 5.84 5.27 4.04 2.70   4.46
EBITDA margin, % ? 36.6% -14.8% -0.03% -38.8% -29.2%   -31.5%
Net margin, % ? 26.2% -66.8% -3.58% -46.0% -46.5%   -44.7%
FCF yield, % ? 3.66% -0.07% 0.30% -5.50% -4.63%   -5.75%
ROE, % ? 20.0% -57.8% -3.76% -47.1% -94.7%   -54.2%
ROA, % ? 9.09% -20.4% -1.11% -10.7% -12.3%   -11.6%
P/E ? 28.8 -16.2 -148.0 -19.8 -19.8   -18.1
P/FCF 27.3 -1 531 332.7 -18.2 -21.6   -17.4
P/S ? 7.53 10.8 5.30 9.13 9.20   8.09
P/BV ? 5.85 9.68 5.78 9.35 18.7   9.81
EV/EBITDA ? 16.2 -62.6 -13 963 -20.7 -27.7   -21.6
Debt/EBITDA -4.35 10.6 3 992 2.82 3.82   4.10
R&D/CAPEX, % 1 284% 1 303% 3 592% 4 144% 3 212%   2 764%
CAPEX/Revenue, % 3.23% 5.63% 2.21% 3.42% 3.56%   4.11%
Ionis Pharmaceuticals shareholders